Literature DB >> 1330905

Polymerase chain reaction-based methods for the detection of human papillomavirus DNA.

P E Gravitt1, M M Manos.   

Abstract

The unprecedented sensitivity of the polymerase chain reaction (PCR) DNA amplification technology provides numerous advantages for the detection of human papillomavirus (HPV) DNA. In this chapter, the principles of the method and its advantages are discussed; disadvantages of the technology and proposed solutions are also presented. To accommodate the complexity of the many distinct HPV types, both type-specific and consensus PCR-based detection methods have evolved. Consensus primer systems, which afford the amplification of a broad spectrum of HPV types, have proven particularly useful in epidemiological studies and in novel virus identification. Since the introduction of PCR into the HPV field, there have been rapid advances and improvements PCR technology. However, standardization of PCR methods for HPV detection is essential for research to fully benefit from the technology. To that end, specific guidelines regarding experimental controls, assessment of analytic sensitivity and data interpretation are outlined here.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1330905

Source DB:  PubMed          Journal:  IARC Sci Publ        ISSN: 0300-5038


  16 in total

1.  Identification of papillomaviruses in scrapings from bovine warts by use of the polymerase chain reaction.

Authors:  N Bloch; R H Sutton; M Breen; P B Spradbrow
Journal:  Vet Res Commun       Date:  1997-01       Impact factor: 2.459

Review 2.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

3.  Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization.

Authors:  C M Wheeler; T Yamada; A Hildesheim; S A Jenison
Journal:  J Clin Microbiol       Date:  1997-01       Impact factor: 5.948

4.  Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

Authors:  Leen-Jan van Doorn; Anco Molijn; Bernhard Kleter; Wim Quint; Brigitte Colau
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  The detection of HPV DNA, the size of tampon specimens and the menstrual cycle.

Authors:  C K Fairley; P M Robinson; S Chen; S N Tabrizi; S M Garland
Journal:  Genitourin Med       Date:  1994-06

6.  Detection and quantitation of human papillomavirus by using the fluorescent 5' exonuclease assay.

Authors:  A Josefsson; K Livak; U Gyllensten
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Risk factors for anogenital human papillomavirus infection in men.

Authors:  Carrie M Nielson; Robin B Harris; Eileen F Dunne; Martha Abrahamsen; Mary R Papenfuss; Roberto Flores; Lauri E Markowitz; Anna R Giuliano
Journal:  J Infect Dis       Date:  2007-09-17       Impact factor: 5.226

8.  Human papillomavirus (HPV) type distribution and serological response to HPV type 6 virus-like particles in patients with genital warts.

Authors:  C E Greer; C M Wheeler; M B Ladner; K Beutner; M Y Coyne; H Liang; A Langenberg; T S Yen; R Ralston
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Co-expression of p16(INK4A) and laminin 5 gamma2 by microinvasive and superficial squamous cell carcinomas in vivo and by migrating wound and senescent keratinocytes in culture.

Authors:  Easwar Natarajan; Marcela Saeb; Christopher P Crum; Sook B Woo; Phillip H McKee; James G Rheinwald
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

10.  A human papilloma virus testing algorithm comprising a combination of the L1 broad-spectrum SPF10 PCR assay and a novel E6 high-risk multiplex type-specific genotyping PCR assay.

Authors:  Dirk van Alewijk; Bernhard Kleter; Maarten Vent; Jean-Marc Delroisse; Maurits de Koning; Leen-Jan van Doorn; Wim Quint; Brigitte Colau
Journal:  J Clin Microbiol       Date:  2013-01-30       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.